What potential mechanisms could underlie the observed association between childhood vaccination and autism? A review of the literature suggests that aluminum adjuvants play a key role.
There is a parallel rise in the association between aluminum adjuvants (AlAd) in vaccines for infants and Autism Spectrum Disorder (ASD).
Injected aluminum (Al) induces behavioral changes in mice.
Brains in ASD patients contain more Al than control.
Numerous mechanisms exist that can explain Al neurotoxic effects.
The consilience of evidence supports AlAd as an etiologic factor in ASD.
A landmark 2018 study titled, Aluminium in brain tissue in autism, found extraordinarily high brain aluminum content is individuals with ASD:
We have made the first measurements of aluminium in brain tissue in ASD and we have shown that the brain aluminium content is extraordinarily high. We have identified aluminium in brain tissue as both extracellular and intracellular with the latter involving both neurones and non-neuronal cells. The presence of aluminium in inflammatory cells in the meninges, vasculature, grey and white matter is a standout observation and could implicate aluminium in the aetiology of ASD.
IPAK-EDU is grateful to FOCAL POINTS (Courageous Discourse) as this piece was originally published there and is included in this news feed with mutual agreement. Read More
Science-based knowledge, not narrative-dictated knowledge, is the goal of WSES, and we will work to make sure that only objective knowledge is used in the formation of medical standards of care and public health policies.
Leave a Reply